New Colorado Bill Would Prohibit 340B Contract Pharmacy Restrictions, Add Hospital Reporting Rules

Colorado state Senate President Pro Tempore Dafna Michaelson Jenet (D) joined four other lawmakers in co-sponsoring a 340B contract pharmacy access bill with certain hospital reporting provisions.
Five high-ranking Colorado state lawmakers have introduced a bill backed by state hospitals and health centers that would prohibit drugmaker [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Indiana Governor Orders Investigation into 340B Hospital Off-Site Clinics as State Legislators Introduce Bill to Significantly Narrow Program Scope

Indiana Gov. Mike Braun (R) issued an executive order to investigate off-site clinic eligibility of state 340B hospitals.
Indiana’s new Republican governor this week ordered an investigation into 340B hospitals’ off-site clinic eligibility on the same day that [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Connecticut Lawmaker Introduces 340B Cost Reporting Bill, Providers Warn of ‘Unnecessary Burden’

A Connecticut lawmaker introduced a bill this week that would require hospitals, pharmacies, PBMs and insurers to report how much they charge patients for 340B drugs.
Connecticut hospitals, pharmacy benefit managers (PBMs), pharmacies and insurance companies would have to report how much they charge patients for [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Weekly Roundup: Updates in West Virginia, Missouri

Key briefs were filed last week in litigation over state contract pharmacy access laws in West Virginia and Missouri.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

NYT Investigation Highlights Federal Law’s Unintended Harm to 340B Providers

A recent New York Times investigation found that part of a COVID-19 relief bill meant to lower drug prices actually increased costs for 340B providers and some of their most vulnerable patients.
A provision in a 2021 COVID-19 relief bill that sought to lower prescription drug prices has actually made some medications [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Four More States Introduce 340B Contract Pharmacy Access Bills in 2025

Lawmakers in the Hawaii state legislature recently introduced companion 340B contract pharmacy access bills, and legislators in North Dakota, Oregon and Oklahoma also introduced similar bills.
Hawaii, North Dakota, Oklahoma and Oregon have joined the quickly growing list of states to introduce 340B contract pharmacy access [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Sanofi Reinstates Contract Pharmacy Restrictions in Kansas, West Virginia Following State Legal Developments

Sanofi will soon begin restricting 340B contract pharmacy use in Kansas and West Virginia after previously exempting providers in those states.
French pharmaceutical giant Sanofi has reinstated its 340B contract pharmacy restrictions in Kansas and West Virginia following legal developments in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Cassidy, Sanders Call for Passing Drug Pricing Bills as Key 340B Committee Holds First Meeting; Kennedy Confirmation Stalls

Senate Health, Education, Labor and Pensions Committee Chairperson U.S. Sen. Bill Cassidy (R-La.) speaks at the panel's first meeting in the 119th Congress on Tuesday.
The Republican and Democratic leaders of the U.S. Senate Health, Energy, Labor and Commerce (HELP) Committee—which has jurisdiction over 340B-related [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal 340B Lobbying Activity Held Steady in Q4 of 2024, Filings Show

More than 350 firms reported lobbying on the 340B program between Oct. 1 and Dec. 31, 2024.
The 340B drug discount program continued to be a hot topic for lobbyists in the final quarter of 2024, keeping [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Just Before Departing, Biden Admin Announces Next 15 Drugs for Medicare Negotiations Amid IRA Uncertainty and 340B Questions

The second group of high-cost prescription drugs chosen for Medicare price negotiations were announced last week just ahead of former President Joe Biden's departure from the White House.
The Department of Health and Human Services (HHS) announced the second group of high-cost prescription drugs chosen for Medicare price [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live